Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia

Aims To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia. Design Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Addiction (Abingdon, England) England), 2013-08, Vol.108 (8), p.1387-1396
Hauptverfasser: Shin, Sonya, Livchits, Viktoria, Connery, Hilary Smith, Shields, Alan, Yanov, Sergei, Yanova, Galina, Fitzmaurice, Garrett M., Nelson, Adrianne K., Greenfield, Shelly F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1396
container_issue 8
container_start_page 1387
container_title Addiction (Abingdon, England)
container_volume 108
creator Shin, Sonya
Livchits, Viktoria
Connery, Hilary Smith
Shields, Alan
Yanov, Sergei
Yanova, Galina
Fitzmaurice, Garrett M.
Nelson, Adrianne K.
Greenfield, Shelly F.
description Aims To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia. Design Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enhancement therapy (BBCET), treatment as usual (TAU) and BCI. Setting and participants In the Tomsk Oblast, hospitalized TB patients diagnosed with alcohol use disorders (AUDs) by the DSM‐IV were referred at the start of TB treatment. Of the 196 participants, the mean age was 41 years and 82% were male. Severe TB (84.7% had cavitary disease) and smoking (92.9%) were common. The majority had a diagnosis of an AUD (63.0%); 27.6% reported nearly daily drinking and consumed a median of 16 standard drinks per day. Measurements Primary outcomes were ‘favorable’ TB outcome (cured, completed treatment) and change in mean number of abstinent days in the last month of study compared with baseline. Change in mean number of heavy drinking days, defined as four drinks per day and five drinks per day for women and men, respectively, and TB adherence, measured as percentage of doses taken as prescribed under direct observation, were secondary outcomes. Analysis based on ‘intention‐to‐treat’ was performed for multivariable analysis. Findings Primary TB and alcohol end‐points between naltrexone and no‐naltrexone or BCI and no‐BCI groups did not differ significantly. TB treatment adherence and change in number of heavy drinking days also did not differ significantly among treatment arms. Among individuals with a prior quitting attempt (n = 111), naltrexone use was associated with an increased likelihood of favorable TB outcomes (92.3% versus 75.9%, P = 0.02). Conclusions In Tomsk Oblast, Russia, tuberculosis patients with severe alcohol use disorders who were not seeking alcohol treatment did not respond to naltrexone or behavioral counselling integrated into tuberculosis care; however, those patients with past attempts to quit drinking had improved tuberculosis outcomes.
doi_str_mv 10.1111/add.12148
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3710528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1430853998</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5468-e4208b8cb307cfeddaa0419b7df8b02fcbd9ffd6963cc83d3f062d8b9ef8896d3</originalsourceid><addsrcrecordid>eNqNkk9v1DAQxSMEokvhwBdAkbhwIO04dhL7glS6_YOoQEVFHC3HHrfuJnGxnUK_Pe5uWQEnfPHY85unJ_sVxUsCeySvfWXMHqkJ44-KBaEtVMAYfVwsQLRNle9hp3gW4zUAdFywp8VOTZkACmxRrI6sRZ3cLU4YY-ltqQbtr_xQpoAqjTil0k0JQwaS81Ncny6DSmjuS18GPyc3YZnmHoOeBx9dLLUKmNvlhR_j6m35ZY7RqefFE6uGiC8e9t3i6_HRxeFpdfb55MPhwVmlG9byClkNvOe6p9Bpi8YoBYyIvjOW91Bb3RthrWlFS7Xm1FALbW14L9ByLlpDd4t3G92buR_R6Ow8qEHeBDeqcCe9cvLvzuSu5KW_lbQj0NQ8C7x5EAj--4wxydFFjcOgJvRzlIRR4A0V4n9Q0vGGQ91k9PU_6LWfw5RfQpKsRWsmWJ2pV3-a37r-_WUZ2N8AP9yAd9s-AXmfBZmzINdZkAfL5brIE9VmwsWEP7cTKqxk29Gukd8-ncjj0-X7jy2cy3P6C0bHuEc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1399324942</pqid></control><display><type>article</type><title>Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Shin, Sonya ; Livchits, Viktoria ; Connery, Hilary Smith ; Shields, Alan ; Yanov, Sergei ; Yanova, Galina ; Fitzmaurice, Garrett M. ; Nelson, Adrianne K. ; Greenfield, Shelly F.</creator><creatorcontrib>Shin, Sonya ; Livchits, Viktoria ; Connery, Hilary Smith ; Shields, Alan ; Yanov, Sergei ; Yanova, Galina ; Fitzmaurice, Garrett M. ; Nelson, Adrianne K. ; Greenfield, Shelly F. ; Tomsk Tuberculosis Alcohol Working Group</creatorcontrib><description>Aims To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia. Design Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enhancement therapy (BBCET), treatment as usual (TAU) and BCI. Setting and participants In the Tomsk Oblast, hospitalized TB patients diagnosed with alcohol use disorders (AUDs) by the DSM‐IV were referred at the start of TB treatment. Of the 196 participants, the mean age was 41 years and 82% were male. Severe TB (84.7% had cavitary disease) and smoking (92.9%) were common. The majority had a diagnosis of an AUD (63.0%); 27.6% reported nearly daily drinking and consumed a median of 16 standard drinks per day. Measurements Primary outcomes were ‘favorable’ TB outcome (cured, completed treatment) and change in mean number of abstinent days in the last month of study compared with baseline. Change in mean number of heavy drinking days, defined as four drinks per day and five drinks per day for women and men, respectively, and TB adherence, measured as percentage of doses taken as prescribed under direct observation, were secondary outcomes. Analysis based on ‘intention‐to‐treat’ was performed for multivariable analysis. Findings Primary TB and alcohol end‐points between naltrexone and no‐naltrexone or BCI and no‐BCI groups did not differ significantly. TB treatment adherence and change in number of heavy drinking days also did not differ significantly among treatment arms. Among individuals with a prior quitting attempt (n = 111), naltrexone use was associated with an increased likelihood of favorable TB outcomes (92.3% versus 75.9%, P = 0.02). Conclusions In Tomsk Oblast, Russia, tuberculosis patients with severe alcohol use disorders who were not seeking alcohol treatment did not respond to naltrexone or behavioral counselling integrated into tuberculosis care; however, those patients with past attempts to quit drinking had improved tuberculosis outcomes.</description><identifier>ISSN: 0965-2140</identifier><identifier>EISSN: 1360-0443</identifier><identifier>DOI: 10.1111/add.12148</identifier><identifier>PMID: 23490304</identifier><identifier>CODEN: ADICE5</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Addiction ; Adult ; Alcohol Abstinence ; Alcohol Deterrents - therapeutic use ; Alcohol interventions ; alcohol use disorders ; Alcoholism ; Alcoholism - complications ; Alcoholism - prevention &amp; control ; Behavior Therapy - methods ; behavioral interventions ; Clinical outcomes ; clinical trial ; Combined Modality Therapy ; Compliance ; Counseling ; Feasibility Studies ; Female ; Humans ; Intervention ; Male ; Medical treatment ; Mycobacterium ; Naltrexone - therapeutic use ; Patient Compliance ; Patients ; Russia ; Russian Federation ; Treatment Outcome ; Tuberculosis ; Tuberculosis - complications ; Tuberculosis - therapy</subject><ispartof>Addiction (Abingdon, England), 2013-08, Vol.108 (8), p.1387-1396</ispartof><rights>2013 The Authors, Addiction © 2013 Society for the Study of Addiction</rights><rights>2013 The Authors, Addiction © 2013 Society for the Study of Addiction.</rights><rights>2013 Society for the Study of Addiction</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5468-e4208b8cb307cfeddaa0419b7df8b02fcbd9ffd6963cc83d3f062d8b9ef8896d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fadd.12148$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fadd.12148$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23490304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shin, Sonya</creatorcontrib><creatorcontrib>Livchits, Viktoria</creatorcontrib><creatorcontrib>Connery, Hilary Smith</creatorcontrib><creatorcontrib>Shields, Alan</creatorcontrib><creatorcontrib>Yanov, Sergei</creatorcontrib><creatorcontrib>Yanova, Galina</creatorcontrib><creatorcontrib>Fitzmaurice, Garrett M.</creatorcontrib><creatorcontrib>Nelson, Adrianne K.</creatorcontrib><creatorcontrib>Greenfield, Shelly F.</creatorcontrib><creatorcontrib>Tomsk Tuberculosis Alcohol Working Group</creatorcontrib><title>Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia</title><title>Addiction (Abingdon, England)</title><addtitle>Addiction</addtitle><description>Aims To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia. Design Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enhancement therapy (BBCET), treatment as usual (TAU) and BCI. Setting and participants In the Tomsk Oblast, hospitalized TB patients diagnosed with alcohol use disorders (AUDs) by the DSM‐IV were referred at the start of TB treatment. Of the 196 participants, the mean age was 41 years and 82% were male. Severe TB (84.7% had cavitary disease) and smoking (92.9%) were common. The majority had a diagnosis of an AUD (63.0%); 27.6% reported nearly daily drinking and consumed a median of 16 standard drinks per day. Measurements Primary outcomes were ‘favorable’ TB outcome (cured, completed treatment) and change in mean number of abstinent days in the last month of study compared with baseline. Change in mean number of heavy drinking days, defined as four drinks per day and five drinks per day for women and men, respectively, and TB adherence, measured as percentage of doses taken as prescribed under direct observation, were secondary outcomes. Analysis based on ‘intention‐to‐treat’ was performed for multivariable analysis. Findings Primary TB and alcohol end‐points between naltrexone and no‐naltrexone or BCI and no‐BCI groups did not differ significantly. TB treatment adherence and change in number of heavy drinking days also did not differ significantly among treatment arms. Among individuals with a prior quitting attempt (n = 111), naltrexone use was associated with an increased likelihood of favorable TB outcomes (92.3% versus 75.9%, P = 0.02). Conclusions In Tomsk Oblast, Russia, tuberculosis patients with severe alcohol use disorders who were not seeking alcohol treatment did not respond to naltrexone or behavioral counselling integrated into tuberculosis care; however, those patients with past attempts to quit drinking had improved tuberculosis outcomes.</description><subject>Addiction</subject><subject>Adult</subject><subject>Alcohol Abstinence</subject><subject>Alcohol Deterrents - therapeutic use</subject><subject>Alcohol interventions</subject><subject>alcohol use disorders</subject><subject>Alcoholism</subject><subject>Alcoholism - complications</subject><subject>Alcoholism - prevention &amp; control</subject><subject>Behavior Therapy - methods</subject><subject>behavioral interventions</subject><subject>Clinical outcomes</subject><subject>clinical trial</subject><subject>Combined Modality Therapy</subject><subject>Compliance</subject><subject>Counseling</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Intervention</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Mycobacterium</subject><subject>Naltrexone - therapeutic use</subject><subject>Patient Compliance</subject><subject>Patients</subject><subject>Russia</subject><subject>Russian Federation</subject><subject>Treatment Outcome</subject><subject>Tuberculosis</subject><subject>Tuberculosis - complications</subject><subject>Tuberculosis - therapy</subject><issn>0965-2140</issn><issn>1360-0443</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk9v1DAQxSMEokvhwBdAkbhwIO04dhL7glS6_YOoQEVFHC3HHrfuJnGxnUK_Pe5uWQEnfPHY85unJ_sVxUsCeySvfWXMHqkJ44-KBaEtVMAYfVwsQLRNle9hp3gW4zUAdFywp8VOTZkACmxRrI6sRZ3cLU4YY-ltqQbtr_xQpoAqjTil0k0JQwaS81Ncny6DSmjuS18GPyc3YZnmHoOeBx9dLLUKmNvlhR_j6m35ZY7RqefFE6uGiC8e9t3i6_HRxeFpdfb55MPhwVmlG9byClkNvOe6p9Bpi8YoBYyIvjOW91Bb3RthrWlFS7Xm1FALbW14L9ByLlpDd4t3G92buR_R6Ow8qEHeBDeqcCe9cvLvzuSu5KW_lbQj0NQ8C7x5EAj--4wxydFFjcOgJvRzlIRR4A0V4n9Q0vGGQ91k9PU_6LWfw5RfQpKsRWsmWJ2pV3-a37r-_WUZ2N8AP9yAd9s-AXmfBZmzINdZkAfL5brIE9VmwsWEP7cTKqxk29Gukd8-ncjj0-X7jy2cy3P6C0bHuEc</recordid><startdate>201308</startdate><enddate>201308</enddate><creator>Shin, Sonya</creator><creator>Livchits, Viktoria</creator><creator>Connery, Hilary Smith</creator><creator>Shields, Alan</creator><creator>Yanov, Sergei</creator><creator>Yanova, Galina</creator><creator>Fitzmaurice, Garrett M.</creator><creator>Nelson, Adrianne K.</creator><creator>Greenfield, Shelly F.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QG</scope><scope>7TK</scope><scope>8BJ</scope><scope>FQK</scope><scope>JBE</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>201308</creationdate><title>Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia</title><author>Shin, Sonya ; Livchits, Viktoria ; Connery, Hilary Smith ; Shields, Alan ; Yanov, Sergei ; Yanova, Galina ; Fitzmaurice, Garrett M. ; Nelson, Adrianne K. ; Greenfield, Shelly F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5468-e4208b8cb307cfeddaa0419b7df8b02fcbd9ffd6963cc83d3f062d8b9ef8896d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Addiction</topic><topic>Adult</topic><topic>Alcohol Abstinence</topic><topic>Alcohol Deterrents - therapeutic use</topic><topic>Alcohol interventions</topic><topic>alcohol use disorders</topic><topic>Alcoholism</topic><topic>Alcoholism - complications</topic><topic>Alcoholism - prevention &amp; control</topic><topic>Behavior Therapy - methods</topic><topic>behavioral interventions</topic><topic>Clinical outcomes</topic><topic>clinical trial</topic><topic>Combined Modality Therapy</topic><topic>Compliance</topic><topic>Counseling</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Intervention</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Mycobacterium</topic><topic>Naltrexone - therapeutic use</topic><topic>Patient Compliance</topic><topic>Patients</topic><topic>Russia</topic><topic>Russian Federation</topic><topic>Treatment Outcome</topic><topic>Tuberculosis</topic><topic>Tuberculosis - complications</topic><topic>Tuberculosis - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shin, Sonya</creatorcontrib><creatorcontrib>Livchits, Viktoria</creatorcontrib><creatorcontrib>Connery, Hilary Smith</creatorcontrib><creatorcontrib>Shields, Alan</creatorcontrib><creatorcontrib>Yanov, Sergei</creatorcontrib><creatorcontrib>Yanova, Galina</creatorcontrib><creatorcontrib>Fitzmaurice, Garrett M.</creatorcontrib><creatorcontrib>Nelson, Adrianne K.</creatorcontrib><creatorcontrib>Greenfield, Shelly F.</creatorcontrib><creatorcontrib>Tomsk Tuberculosis Alcohol Working Group</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Addiction (Abingdon, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shin, Sonya</au><au>Livchits, Viktoria</au><au>Connery, Hilary Smith</au><au>Shields, Alan</au><au>Yanov, Sergei</au><au>Yanova, Galina</au><au>Fitzmaurice, Garrett M.</au><au>Nelson, Adrianne K.</au><au>Greenfield, Shelly F.</au><aucorp>Tomsk Tuberculosis Alcohol Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia</atitle><jtitle>Addiction (Abingdon, England)</jtitle><addtitle>Addiction</addtitle><date>2013-08</date><risdate>2013</risdate><volume>108</volume><issue>8</issue><spage>1387</spage><epage>1396</epage><pages>1387-1396</pages><issn>0965-2140</issn><eissn>1360-0443</eissn><coden>ADICE5</coden><abstract>Aims To test the feasibility and effectiveness of brief counseling intervention (BCI) and naltrexone integrated into tuberculosis (TB) care in Tomsk, Russia. Design Using a factorial randomized controlled trial design, patients were randomized into: naltrexone (NTX), brief behavioral compliance enhancement therapy (BBCET), treatment as usual (TAU) and BCI. Setting and participants In the Tomsk Oblast, hospitalized TB patients diagnosed with alcohol use disorders (AUDs) by the DSM‐IV were referred at the start of TB treatment. Of the 196 participants, the mean age was 41 years and 82% were male. Severe TB (84.7% had cavitary disease) and smoking (92.9%) were common. The majority had a diagnosis of an AUD (63.0%); 27.6% reported nearly daily drinking and consumed a median of 16 standard drinks per day. Measurements Primary outcomes were ‘favorable’ TB outcome (cured, completed treatment) and change in mean number of abstinent days in the last month of study compared with baseline. Change in mean number of heavy drinking days, defined as four drinks per day and five drinks per day for women and men, respectively, and TB adherence, measured as percentage of doses taken as prescribed under direct observation, were secondary outcomes. Analysis based on ‘intention‐to‐treat’ was performed for multivariable analysis. Findings Primary TB and alcohol end‐points between naltrexone and no‐naltrexone or BCI and no‐BCI groups did not differ significantly. TB treatment adherence and change in number of heavy drinking days also did not differ significantly among treatment arms. Among individuals with a prior quitting attempt (n = 111), naltrexone use was associated with an increased likelihood of favorable TB outcomes (92.3% versus 75.9%, P = 0.02). Conclusions In Tomsk Oblast, Russia, tuberculosis patients with severe alcohol use disorders who were not seeking alcohol treatment did not respond to naltrexone or behavioral counselling integrated into tuberculosis care; however, those patients with past attempts to quit drinking had improved tuberculosis outcomes.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23490304</pmid><doi>10.1111/add.12148</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0965-2140
ispartof Addiction (Abingdon, England), 2013-08, Vol.108 (8), p.1387-1396
issn 0965-2140
1360-0443
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3710528
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Addiction
Adult
Alcohol Abstinence
Alcohol Deterrents - therapeutic use
Alcohol interventions
alcohol use disorders
Alcoholism
Alcoholism - complications
Alcoholism - prevention & control
Behavior Therapy - methods
behavioral interventions
Clinical outcomes
clinical trial
Combined Modality Therapy
Compliance
Counseling
Feasibility Studies
Female
Humans
Intervention
Male
Medical treatment
Mycobacterium
Naltrexone - therapeutic use
Patient Compliance
Patients
Russia
Russian Federation
Treatment Outcome
Tuberculosis
Tuberculosis - complications
Tuberculosis - therapy
title Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T13%3A40%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20alcohol%20treatment%20interventions%20integrated%20into%20routine%20tuberculosis%20care%20in%20Tomsk,%20Russia&rft.jtitle=Addiction%20(Abingdon,%20England)&rft.au=Shin,%20Sonya&rft.aucorp=Tomsk%20Tuberculosis%20Alcohol%20Working%20Group&rft.date=2013-08&rft.volume=108&rft.issue=8&rft.spage=1387&rft.epage=1396&rft.pages=1387-1396&rft.issn=0965-2140&rft.eissn=1360-0443&rft.coden=ADICE5&rft_id=info:doi/10.1111/add.12148&rft_dat=%3Cproquest_pubme%3E1430853998%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1399324942&rft_id=info:pmid/23490304&rfr_iscdi=true